DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $329,000 | -42.5% | 1,000 | -61.2% | 0.16% | -48.3% |
Q4 2020 | $572,000 | -40.2% | 2,575 | -42.1% | 0.30% | -48.4% |
Q3 2020 | $957,000 | +17.6% | 4,445 | -3.5% | 0.58% | +2.5% |
Q2 2020 | $814,000 | +52.1% | 4,605 | +19.1% | 0.57% | -25.0% |
Q1 2020 | $535,000 | -56.8% | 3,865 | -52.0% | 0.76% | -10.8% |
Q4 2019 | $1,237,000 | +8.3% | 8,060 | +1.9% | 0.85% | -4.0% |
Q3 2019 | $1,142,000 | +72.0% | 7,910 | +70.3% | 0.89% | +65.9% |
Q2 2019 | $664,000 | -2.2% | 4,645 | -9.7% | 0.54% | -7.4% |
Q1 2019 | $679,000 | +26.9% | 5,145 | -0.8% | 0.58% | -6.3% |
Q4 2018 | $535,000 | -5.0% | 5,185 | 0.0% | 0.62% | +43.1% |
Q3 2018 | $563,000 | +10.0% | 5,185 | 0.0% | 0.43% | +6.4% |
Q2 2018 | $512,000 | +0.4% | 5,185 | -0.6% | 0.41% | -3.1% |
Q1 2018 | $510,000 | -4.1% | 5,215 | -9.1% | 0.42% | +5.3% |
Q4 2017 | $532,000 | +8.1% | 5,735 | 0.0% | 0.40% | +2.6% |
Q3 2017 | $492,000 | -56.1% | 5,735 | -56.8% | 0.39% | -61.4% |
Q2 2016 | $1,120,000 | – | 13,275 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |